ONC1-13B
ONC1-13B is a potent androgen receptor (AR) antagonist with the activity of effectively inhibiting PSA expression in prostate cancer cells. ONC1-13B can effectively inhibit PSA expression and prostate cancer cell proliferation under DHT stimulation. ONC1-13B exerts its anti-tumor effect by preventing androgen from binding to AR and its nuclear translocation[1].
Product Specifications
CAS Number
1351185-54-0
UNSPSC
12352005
Target
Androgen Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/onc1-13b.html
Smiles
O=C1[C@]2(CCOC2)N(C3=CC(F)=C(C=C3)C(NC)=O)C(N1C4=CC(C(F)(F)F)=C(C=C4)C#N)=S
Molecular Formula
C22H16F4N4O3S
Molecular Weight
492.45
References & Citations
[1]Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer Treatment
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Bovine Tubulin alpha-1B chain
Recombinant Bovine Tubulin alpha-1B chain
Recombinant Bovine Tubulin alpha-1B chain
Recombinant Bovine Tubulin alpha-1B chain
Recombinant Bovine Tubulin alpha-1B chain